Resistant hypertension is high blood pressure that stays above target despite taking three or more blood pressure medications at their maximum tolerated doses. It also includes people whose blood pressure only reaches goal with four or more medications. About 5% of all people with hypertension meet this definition, though some analyses of treated patients put the number closer to 10%.
The condition isn’t just “hard to treat” blood pressure. It carries a meaningfully higher risk of heart attack, stroke, and kidney damage compared to hypertension that responds well to standard treatment. Understanding what qualifies, what causes it, and what can be done about it makes a real difference in outcomes.
How It’s Defined and Diagnosed
The American Heart Association defines resistant hypertension as blood pressure that remains at or above 140/90 mmHg while a person is taking three different classes of blood pressure medication, one of which should be a diuretic (a water pill). All three medications need to be at their maximum or highest tolerated doses. If your blood pressure is controlled but you need four or more drugs to get there, that also counts as resistant hypertension.
Before confirming the diagnosis, two important things have to be ruled out. First, medication adherence. Skipping doses or not taking medications as prescribed is one of the most common reasons blood pressure appears resistant. Second, something called the white-coat effect, where blood pressure reads high in a doctor’s office but is actually normal at home. Up to one third of people who appear to have resistant hypertension are actually experiencing this white-coat effect. The only reliable way to distinguish the two is with ambulatory blood pressure monitoring, where you wear a cuff that takes readings automatically over 24 hours while you go about your day. Without this step, it’s impossible to know whether the resistance is real.
Why It Happens
In many cases, resistant hypertension has an identifiable underlying cause. The most common one is a condition called primary aldosteronism, where the adrenal glands produce too much of a hormone called aldosterone. This hormone tells the kidneys to hold on to sodium and water, which raises blood pressure. Among people with confirmed resistant hypertension, 10% to 20% have primary aldosteronism, and many don’t know it. Other secondary causes include narrowing of the arteries that supply the kidneys, thyroid disorders, and obstructive sleep apnea.
Sometimes there’s no single hidden cause. Factors like older age, obesity, high sodium intake, chronic kidney disease, and diabetes all make blood pressure harder to control with standard medications. These conditions often overlap, creating a compounding effect that pushes blood pressure beyond what three drugs can handle.
The Cardiovascular Risks
Resistant hypertension isn’t just a numbers problem on a blood pressure cuff. It does real damage over time. One study found that people with uncontrolled resistant hypertension had roughly 2.5 times the risk of dying from any cause compared to those whose resistant hypertension was brought under control, even after accounting for other cardiovascular risk factors. The sustained pressure strains blood vessel walls, thickens the heart muscle, and accelerates kidney decline. Getting blood pressure to target, even if it requires multiple medications or procedures, meaningfully reduces these risks.
Sodium Reduction Makes a Striking Difference
For most people with high blood pressure, cutting salt helps a little. For people with resistant hypertension, the effect is dramatic. In a randomized trial, switching from a high-salt to a low-salt diet lowered office systolic blood pressure by an average of 22.7 mmHg and diastolic by 9.1 mmHg. That’s a reduction comparable to adding an entire medication. The effect held up on 24-hour ambulatory monitoring too, with systolic pressure dropping about 20 mmHg around the clock.
This outsized response likely reflects the role sodium plays in the underlying biology of resistant hypertension. Many of these patients retain more sodium than average, whether because of excess aldosterone, kidney impairment, or other mechanisms. Reducing intake to under 2,000 mg per day (roughly one teaspoon of table salt) can be one of the most impactful single changes a person makes.
The Role of a Fourth Medication
When three medications aren’t enough, the most effective next step for most people is adding a type of drug that blocks aldosterone’s effects. The landmark PATHWAY-2 trial, published in The Lancet, compared several options as a fourth add-on drug in people with confirmed resistant hypertension. The trial found that an aldosterone blocker (spironolactone) was the most effective choice by a large margin in the overwhelming majority of patients. This makes biological sense: even in people who don’t have full-blown primary aldosteronism, excess aldosterone activity often plays a role in keeping blood pressure elevated.
Spironolactone isn’t without side effects. It can raise potassium levels, which requires monitoring through blood tests, and some men experience breast tenderness. But for people with truly resistant hypertension, it often brings blood pressure to target when nothing else has.
Catheter-Based Procedures
In late 2023, the FDA approved two catheter-based systems that treat hypertension by disrupting overactive nerve signals between the kidneys and the brain. The procedure, called renal denervation, involves threading a thin catheter into the arteries that supply the kidneys and delivering either ultrasound or radiofrequency energy to quiet the nerves running along those vessels.
The blood pressure reductions are modest but consistent. In the SPYRAL HTN-ON MED trial, renal denervation lowered 24-hour systolic blood pressure by about 5.7 mmHg more than a sham procedure at two years. The RADIANCE-HTN TRIO trial, using an ultrasound-based system, showed a sustained 8 mmHg systolic reduction that held steady from 2 months out to 3 years. These numbers won’t replace medications for most people, but for someone whose blood pressure remains dangerously high despite multiple drugs and lifestyle changes, even a 5 to 8 mmHg drop can shift the risk picture meaningfully. The procedures are minimally invasive, typically done through a small puncture in the wrist or groin, with patients going home the same day.
Sorting Out True Resistance From Pseudo-Resistance
A significant portion of people initially labeled with resistant hypertension don’t actually have it. Beyond the white-coat effect, suboptimal medication combinations are a common culprit. Not every three-drug regimen is equally effective, and a poor match of drug classes can leave blood pressure elevated even at full doses. Switching to a more rational combination sometimes solves the problem without adding a fourth drug.
Medication adherence is the other major factor. Studies using blood and urine tests to detect drug levels have consistently found that a substantial number of patients prescribed multiple blood pressure medications aren’t taking all of them consistently. This isn’t a character flaw; complex medication regimens are genuinely difficult to maintain. But it means the first step in evaluating apparent resistance is often a frank conversation about what’s actually being taken, ideally paired with objective testing when available.
If adherence is confirmed, the white-coat effect is excluded through ambulatory monitoring, and blood pressure still won’t budge, screening for secondary causes like primary aldosteronism and sleep apnea becomes essential. Identifying and treating these conditions can sometimes resolve the resistance entirely.